HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guillaume Direz Selected Research

Guillaume Direz Research Topics

Disease

2Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
03/2024 - 01/2022
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2023
1Infections
01/2022
1Vasculitis (Vasculitides)
12/2018
1Arthritis (Polyarthritis)
12/2018
1Demyelinating Diseases (Demyelinating Disease)
05/2013
1Gout
12/2012
1Chronic Kidney Failure (Chronic Renal Failure)
12/2012
1Rheumatic Diseases (Rheumatism)
12/2011
1Uveitis
12/2011
1Rheumatoid Arthritis
12/2011
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
12/2011
1Spondylarthropathies
12/2011
1Inflammation (Inflammations)
12/2011

Drug/Important Bio-Agent (IBA)

2GlucocorticoidsIBA
03/2024 - 01/2022
2C-Reactive ProteinIBA
03/2024 - 01/2022
2tocilizumab (atlizumab)FDA Link
03/2024 - 01/2022
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2023 - 12/2018
1Rituximab (Mabthera)FDA Link
11/2023
1Azathioprine (Imuran)FDA LinkGeneric
11/2023
1dimemorfan (AT 17)IBA
01/2022
1Prednisone (Sone)FDA LinkGeneric
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
12/2012
1Infliximab (Remicade)FDA Link
12/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2011
1Etanercept (Enbrel)FDA Link
12/2011
1Adalimumab (Humira)FDA Link
12/2011
1Monoclonal AntibodiesIBA
12/2011
1Tumor Necrosis Factor InhibitorsIBA
12/2011

Therapy/Procedure

5Therapeutics
11/2023 - 12/2011